Supplemental Oxygen Protects Heart Against Acute Myocardial Infarction
Myocardial infarction (MI), which occurs often due to acute ischemia followed by reflow, is associated with irreversible loss (death) of cardiomyocytes. If left untreated, MI will lead to progressive loss of viable cardiomyocytes, deterioration of cardiac function, and congestive heart failure. Whil...
Main Authors: | Anjali M. Prabhat, M. Lakshmi Kuppusamy, Shan K. Naidu, Sarath Meduru, Praneeth T. Reddy, Abishai Dominic, Mahmood Khan, Brian K. Rivera, Periannan Kuppusamy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcvm.2018.00114/full |
Similar Items
-
Hyperoxygenation as a Therapeutic Supplement for Treatment of Triple Negative Breast Cancer
by: Jesse M. Mast, et al.
Published: (2018-11-01) -
Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
by: Lucas Citro, et al.
Published: (2014-01-01) -
Sivelestat Attenuates Myocardial Reperfusion Injury during Brief Low Flow Postischemic Infusion
by: Sverre E. Aune, et al.
Published: (2013-01-01) -
Cyclic Nigerosyl-Nigerose as Oxygen Nanocarrier to Protect Cellular Models from Hypoxia/Reoxygenation Injury: Implications from an In Vitro Model
by: Claudia Penna, et al.
Published: (2021-04-01) -
Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction
by: Cory Trankle, MD, et al.
Published: (2016-10-01)